2
Clinical Trials associated with Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)A Randomized, Double-blind, Placebo-controlled in Parallel, Multicenter Phase III Trial of Recombinant Human Apo-2 Ligand for Injection(Dulanermin for Injection)in the Treatment of Advanced Non-small Cell Lung Cancer
The trial is to evaluate the efficacy and safety of recombinant human Apo-2 ligand in treating patients with advanced retreated non-small cell lung cancer
注射用重组人凋亡素2配体治疗晚期非小细胞肺癌随机、双盲、安慰剂平行对照、多中心Ⅲ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of recombinant human apoptosis-inducing factor 2 ligand for the treatment of advanced non-small cell lung cancer
观察和评价注射用重组人凋亡素2配体对晚期复治非小细胞肺癌患者的有效性和安全性
[Translation] To observe and evaluate the efficacy and safety of recombinant human apoptosis-2 ligand for injection in patients with advanced recurrent non-small cell lung cancer
100 Clinical Results associated with Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)
100 Translational Medicine associated with Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)
100 Patents (Medical) associated with Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)
100 Deals associated with Dulanermin(Shanghai Gebaide Biotechnology Co., Ltd.)